SCHEMBL19164313

SCHEMBL19164313

N#Cc1ccc(-c2nc(-c3ccncc3)nc(-c3ccc4c(c3)-c3ccccc3-c3ccccc3C43c4ccccc4-c4ccccc43)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 8/20 0.40
▸ PDK2 Q15119 3/20 0.40
▸ MAPK14 Q16539 3/20 0.39
▸ MAPK13 O15264 1/20 0.39
▸ RAF1 P04049 1/20 0.39
▸ MAPK12 P53778 1/20 0.39
▸ MAPK11 Q15759 1/20 0.39
▸ ABCB1 P08183 3/20 0.39
▸ USP2 O75604 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ GCGR P47871 1/20 0.36
▸ CYP11B2 P19099 2/20 0.35
▸ CYP19A1 P11511 1/20 0.35
▸ CYP11B1 P15538 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19172959 0.94 PDK2 (0.44) ABCG2PDK2ABCB1MEN1KMT2A
SCHEMBL19164046 0.93 PDK2 (0.41) ABCG2PDK2MAPK14MAPK13RAF1
SCHEMBL19172213 0.93 PDK2 (0.45) ABCG2PDK2MAPK14MAPK13RAF1
SCHEMBL19164578 0.92 PDK2 (0.43) ABCG2PDK2MAPK14MAPK13RAF1
SCHEMBL19164134 0.92 ABCG2 (0.41) ABCG2PDK2MAPK14MAPK13RAF1
SCHEMBL19164574 0.92 ABCG2 (0.41) ABCG2PDK2MAPK14MAPK13RAF1
SCHEMBL19172258 0.92 PDK2 (0.47) ABCG2PDK2MAPK14MAPK13RAF1
SCHEMBL19164552 0.91 ABCG2 (0.46) ABCG2PDK2ABCB1CYP1A2CYP3A4
SCHEMBL19164404 0.91 PDK2 (0.42) ABCG2PDK2MAPK14MAPK13RAF1
SCHEMBL19164590 0.91 PDK2 (0.42) ABCG2PDK2MAPK14MAPK13RAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170213978-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2017-07-27 — — US disclosed
US-20170213978-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2017-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170213978-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME OR51E2, OR10J3, ESR1 ABCG2 2072/4885PDK2 1279/4885MAPK14 2554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback